$549 Million is the total value of SPHERA FUNDS MANAGEMENT LTD.'s 83 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 55.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDcall | $51,140,759 | -16.6% | 5,013,800 | -38.4% | 9.32% | -2.7% |
| SNY | Sell | SANOFIsponsored adr | $26,793,985 | -6.1% | 499,515 | -5.7% | 4.88% | +9.5% |
| JNJ | Sell | JOHNSON & JOHNSON | $14,769,928 | -25.5% | 94,831 | -20.9% | 2.69% | -13.1% |
| AMZN | Sell | AMAZON COM INC | $12,114,536 | -25.2% | 95,300 | -23.3% | 2.21% | -12.8% |
| PRAX | Sell | PRAXIS PRECISION MEDICINES I | $8,294,042 | -17.7% | 4,850,317 | -44.7% | 1.51% | -4.0% |
| LLY | Sell | ELI LILLY & CO | $7,621,875 | +3.6% | 14,190 | -9.6% | 1.39% | +20.8% |
| Sell | SHL TELEMEDICINE LTDsponsored ads | $6,956,523 | -12.6% | 632,256 | -11.5% | 1.27% | +1.9% | |
| ABBV | Sell | ABBVIE INC | $6,856,760 | -9.1% | 46,000 | -17.9% | 1.25% | +6.0% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $6,393,487 | -15.8% | 36,101 | -9.7% | 1.16% | -1.8% |
| NICE | Sell | NICE LTDsponsored adr | $6,371,940 | -64.7% | 37,482 | -57.2% | 1.16% | -58.8% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $6,120,000 | -22.6% | 600,000 | -42.9% | 1.12% | -9.7% |
| MRUS | Sell | MERUS N V | $5,973,592 | -18.5% | 253,333 | -9.0% | 1.09% | -4.9% |
| Sell | DISC MEDICINE INC | $5,233,478 | -30.9% | 111,398 | -34.7% | 0.95% | -19.4% | |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $4,283,230 | -8.7% | 209,040 | -11.4% | 0.78% | +6.6% |
| PFE | Sell | PFIZER INC | $2,985,300 | -41.9% | 90,000 | -35.7% | 0.54% | -32.2% |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $2,061,000 | +0.2% | 180,000 | -10.0% | 0.38% | +16.8% |
| RZLT | Sell | REZOLUTE INC | $1,315,657 | -42.5% | 996,710 | -13.8% | 0.24% | -32.8% |
| Sell | MEDIWOUND LTD | $1,154,791 | -2.5% | 108,533 | -2.3% | 0.21% | +13.5% | |
| SELB | Sell | SELECTA BIOSCIENCES INC | $797,265 | -65.1% | 752,137 | -63.1% | 0.14% | -59.3% |
| Exit | ARBE ROBOTICS LTDordinary shares | $0 | – | -43,165 | -100.0% | -0.02% | – | |
| CYCC | Exit | CYCLACEL PHARMACEUTICALS INC | $0 | – | -250,000 | -100.0% | -0.02% | – |
| INFI | Exit | INFINITY PHARMACEUTICALS INC | $0 | – | -1,476,000 | -100.0% | -0.05% | – |
| PMVP | Exit | PMV PHARMACEUTICALS INC | $0 | – | -187,800 | -100.0% | -0.18% | – |
| DYN | Exit | DYNE THERAPEUTICS INC | $0 | – | -119,918 | -100.0% | -0.21% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -418,562 | -100.0% | -0.22% | – |
| ALT | Exit | ALTIMMUNE INC | $0 | – | -500,000 | -100.0% | -0.28% | – |
| BBIO | Exit | BRIDGEBIO PHARMA INCcall | $0 | – | -130,000 | -100.0% | -0.35% | – |
| Exit | ARCELLX INC | $0 | – | -77,488 | -100.0% | -0.38% | – | |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -213,462 | -100.0% | -0.51% | – |
| Exit | ENLIGHT RENEWABLE ENERGY LTD | $0 | – | -211,586 | -100.0% | -0.59% | – | |
| QCOM | Exit | QUALCOMM INC | $0 | – | -32,000 | -100.0% | -0.60% | – |
| ARGX | Exit | ARGENX SEput | $0 | – | -10,000 | -100.0% | -0.61% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -134,414 | -100.0% | -0.83% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -128,000 | -100.0% | -0.94% | – |
| ENPH | Exit | ENPHASE ENERGY INCcall | $0 | – | -40,000 | -100.0% | -1.05% | – |
| CAMT | Exit | CAMTEK LTDord | $0 | – | -189,494 | -100.0% | -1.05% | – |
| MSFT | Exit | MICROSOFT CORPcall | $0 | – | -21,000 | -100.0% | -1.12% | – |
| GNRC | Exit | GENERAC HLDGS INCcall | $0 | – | -52,500 | -100.0% | -1.22% | – |
| NVMI | Exit | NOVA LTD | $0 | – | -70,000 | -100.0% | -1.28% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INCcall | $0 | – | -78,300 | -100.0% | -1.40% | – |
| TSEM | Exit | TOWER SEMICONDUCTOR LTDput | $0 | – | -332,100 | -100.0% | -1.95% | – |
| AMD | Exit | ADVANCED MICRO DEVICES INCcall | $0 | – | -120,000 | -100.0% | -2.13% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -126,000 | -100.0% | -7.27% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICAL-SP ADR | 36 | Q3 2023 | 8.4% |
| MERCK & CO INC NEW | 35 | Q3 2023 | 8.4% |
| NICE Systems Ltd | 27 | Q3 2023 | 4.4% |
| BIOGEN INC | 26 | Q3 2023 | 6.7% |
| AMICUS THERAPEUTICS INC | 26 | Q2 2022 | 4.3% |
| PFIZER INC | 25 | Q3 2023 | 9.2% |
| SAREPTA THERAPEUTICS INC | 25 | Q3 2023 | 3.2% |
| JOHNSON & JOHNSON | 24 | Q3 2023 | 8.0% |
| UNIQURE NV | 23 | Q3 2023 | 1.2% |
| SYNDAX PHARMACEUTICALS INC | 22 | Q3 2023 | 3.9% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyclacel Pharmaceuticals, Inc. | February 06, 2023 | 250,000 | 2.0% |
| Altimmune, Inc. | February 14, 2022 | 1,244,241 | 3.1% |
| Allot Ltd. | February 16, 2021 | 1,129,054 | 3.2% |
| Larimar Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Neos Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Orgenesis Inc. | February 16, 2021 | 525,216 | 0.0% |
| Sio Gene Therapies Inc. | February 16, 2021 | ? | ? |
| X4 Pharmaceuticals, Inc | February 16, 2021 | 250,000 | 0.0% |
| Axovant Gene Therapies Ltd. | February 25, 2020 | 2,931,017 | 8.0% |
| Axovant Gene Therapies Ltd. | February 11, 2020 | 398,540 | 1.8% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-08 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-10 |
| SC 13G | 2023-08-30 |
View SPHERA FUNDS MANAGEMENT LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.